2023-11-08 15:30:00

Global TCV Vaccines Market Size to grow USD 958 Million by 2030 | CAGR of 12.5%; Spherical Insights & Consulting

Logo GlobeNewswire
GlobeNewswire

The Global TCV Vaccines Market Size was valued at USD 332 million in 2021 and the worldwide TCV vaccines market share is expected to reach USD 958 million by 2030. North America emerged as the largest market for the global TCV Vaccines Market, with a market share of around 34% and 332 million of the market revenue in 2021. Companies Covered: GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech, PT BIO FARMA, PaxVax, Inc, AstraZeneca PLC, Emergent BioSolutions Inc., Daiichi Sankyo Co. Ltd, Johnson & Johnson, Merck & Co., Novavax Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd. And we have covered more prominent key players in the final report.

AD
AD

New York, United States , Nov. 08, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global TCV Vaccines Market Size to grow from USD 332 million in 2021 to USD 958 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period. The TCV vaccines market has grown due to the increasing prevalence of typhoid, increasing government initiatives, increasing antibiotic resistance, and adoption of inorganic growth strategies. The Asia Pacific is expected to grow the fastest during the forecast period followed by North America and Europe.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/1271

View a detailed Table of Content here

The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.

Browse key industry insights spread across 231 pages with 108 market data tables and figures & charts from the report Global TCV Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Brand (Ty21a ( Vivotif), ViCPS ( Typhim Vi), Vi-TT ( Peda-typhTM), and Typbar TCV), By Distribution Channel (Public, UNICEF, Tender ( Govt.), and Private), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030. in detail along with the table of contents.

AD
AD

Buy Now Full Report: https://www.sphericalinsights.com/checkout/1271

The Ty21a (Vivotif) segment accounts for the largest market size during the forecast period

Based on the vaccine brand, the global TCV vaccines market is categorized into annual Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV. The Ty21a (Vivotif) segment accounts for the largest market size during the forecast period. Ty21a vaccines are good at lowering the risk of typhoid fever, and they have low rates of side effects. About half of typhoid cases can be stopped in the first three years after getting the oral Ty21a vaccine. In the first year, the injectable Vi polysaccharide vaccine stopped about two-thirds of typhoid cases, and by the end of the third year, it had stopped 55% of all typhoid cases. The effectiveness of this vaccine has only been shown in kids over the age of two.

The public segment to hold a higher CAGR during the forecast period

Based on the distribution channel, the TCV vaccines market is categorized into Public, UNICEF, Tender (Govt.), and Private. The public segment to hold higher CAGR during the forecast period. The public segment is dominating because of the increasing awareness among people due to the increase in government initiatives.

North America is estimated to account for the highest market share in 2021.

The Global TCV vaccines market has been segmented into five major regions: Asia-Pacific, Europe, APAC, Latin America, and MEA. Because its healthcare infrastructure is growing quickly and the government is spending more on healthcare. The rise is due to the increase in the pharmaceutical industry, a world-class healthcare system, and a lot of money people spend on healthcare. As more and more TCV vaccines are being made, the market is likely to grow. Asia-Pacific to hold a higher CAGR during the forecast period.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/1271

Key Companies & Recent Developments: The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global TCV vaccines market include GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech, PT BIO FARMA, PaxVax, Inc, AstraZeneca PLC, Emergent BioSolutions Inc., Daiichi Sankyo Co. Ltd, Johnson & Johnson, Merck & Co., Novavax Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd. And others prominent key players.

AD
AD

Browse Related Reports

Global Bovine Mastitis Market Size, Share, and COVID-15.5 Impact Analysis, By Type (Clinical and Sub-Clinical), By Product (Antibiotics, Surgery, Vaccines, Pain Killers, and Others), By Route of Administration (Intra-Mammary and Systemic), By Therapy (Lactating Period and Dry Period), By End Users (Hospitals, Veterinary Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 2030.

https://www.sphericalinsights.com/reports/bovine-mastitis-market

Global Biologics Market Size, Share & Trends Analysis Report, COVID-19 Impact Analysis Report, By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi), By Disease Category, By Manufacturing, And, By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis, and Forecast till 2030.

https://www.sphericalinsights.com/reports/biologics-market

Contact Us:

For More Information on Your Target Market, Please Contact Us Below:

Phone:+1 303 800 4326 (the U.S.)

Phone:+91 90289 24100 (APAC)

Email:[email protected], [email protected]

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us:LinkedIn|Facebook|Twitter


Continue read on globenewswire.com

AD
Logo GlobeNewswire
EconomyPress Release2023-10-31 11:00:00
The Global Eosinophilic Esophagitis Market Size was valued at USD 138.4 million in 2021 and the worldwide eosinophilic esophagitis market is expected to...

Logo GlobeNewswire
EconomyPress Release2023-10-18 12:00:00
The Global Topical Corticosteroids Market Size was valued at USD 4.85 billion in 2021 and the global Topical Corticosteroids Market is expected to reach USD...

Logo GlobeNewswire
EconomyPress Release2023-10-19 15:00:00
The Global Small Molecule Injectable Drugs Market Size was valued at USD 188.9 billion in 2021. The global small molecule injectable drugs market is expected...

Logo GlobeNewswire
EconomyPress Release2023-10-20 16:30:00
The Global Targeted Drug Delivery Market Size was valued at USD 6,960 million in 2021, the global Targeted Drug Delivery Market is expected to reach USD...

Logo GlobeNewswire
EconomyPress Release2023-10-26 10:00:00
The Global Yellow Fever Treatment Market Size was valued at USD 470.5 billion in 2021 and the world yellow fever treatment market share is expected to reach...

Logo GlobeNewswire
EconomyPress Release2023-10-26 09:00:00
The Global Systemic Scleroderma Treatment Market Size was valued at USD 1,520.1 million in 2021 and the worldwide systemic scleroderma treatment market share...

Logo GlobeNewswire
EconomyPress Release2023-10-28 11:00:00
The Global Diabetes Devices Market Size was valued at USD 26.7 billion in 2021 and the global diabetes devices market is expected to reach USD 55.6 billion...

Logo GlobeNewswire
EconomyPress Release2023-11-07 19:00:00
Global Meningococcal Vaccines Market size to grow from USD 2.88 billion in 2021 to USD 5.07 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 6.5%...

Logo GlobeNewswire
EconomyPress Release2023-10-24 10:30:00
The Global Automotive Artificial PVC Leather Market Size was valued at USD 1,250 Million in 2021 and the worldwide automotive artificial PVC leather market...

Logo GlobeNewswire
EconomyPress Release2023-10-18 09:30:00
The Global Heparin Market Size was valued at USD 6,540 billion in 2021 and the global heparin market share is expected to reach USD 11,507 billion by 2030;...

Logo GlobeNewswire
EconomyPress Release2023-10-20 17:00:00
The Global Therapeutic Contact Lenses Market Size was valued at USD 2,830.96 billion in 2021, the global therapeutic contact lenses market is expected to...

Logo GlobeNewswire
EconomyPress Release2023-10-24 16:30:00
The Global Blow Molded Plastic Market Size was valued at USD 75.9 billion in 2021 and the worldwide blow molded plastic market share is expected to reach USD...

Logo GlobeNewswire
EconomyPress Release2023-10-24 09:00:00
The Global Allergy Immunotherapy Market Size was valued at USD 2.0 billion in 2021 and the worldwide allergy immunotherapy market share is expected to reach...

Logo GlobeNewswire
EconomyPress Release2023-10-24 17:00:00
The Global Bovine Mastitis Market Size was valued at USD 1.50 billion in 2021 and the worldwide bovine mastitis market is expected to reach USD 2.42 billion...

Logo GlobeNewswire
EconomyPress Release2023-10-24 17:30:00
The Global Bovine Serum Albumin Market Size was valued at USD 5.58 billion in 2021 and the worldwide bovine serum albumin market is expected to reach USD...

Logo GlobeNewswire
EconomyPress Release2023-10-12 14:30:00
The Global Graphene Market Size was valued at USD 87.0 million in 2021. The market is growing at a CAGR of 30% from 2021 to 2030; Companies Covered: Angstron...

Logo GlobeNewswire
EconomyPress Release2023-11-03 11:00:00
The Global Local Anesthesia Drugs Market Size was valued at USD 2,568.64 million in 2021 and the worldwide local anesthesia drugs market is expected to reach...

Logo GlobeNewswire
EconomyPress Release2023-10-31 11:30:00
The Global Protective Clothing Market Size was valued at USD 9.1 billion in 2021 and the worldwide protective clothing market is expected to reach USD 15.2...

Logo GlobeNewswire
TechnologyPress Release2023-10-17 10:59:00
Key Companies Outlined in the Global Antihypertensive Drugs Market Research Report by Kenneth Research Include AstraZeneca, Boehringer Ingelheim Internatonal...

Logo GlobeNewswire
EconomyPress Release2023-11-01 16:30:00
The Global Railroad Equipment Market Size was valued at USD 75 Billion in 2021, the market is projected to grow USD 93.80 Billion in 2030, at a CAGR of...